This publication provides an overview of the PATH Children's Vaccine Program's achievements worldwide, with a special focus on China, India, and Indonesia.

Publication date: 2004

Region: Global

This brochure outlines PATH's work in China, with emphasis on public-private partnerships for product development. Areas of focus include vaccines and immunization, health technologies, and women's health.

Publication date: November 2012

Region: Asia

This brochure outlines PATH's work in India, where we're addressing a range of health problems while leveraging the country’s growing capacity to innovate and contribute to global health solutions.

Publication date: November 2012

Region: Asia

The PATH Malaria Vaccine Initiative (MVI) is a vaccine development program of PATH. This fact sheet provides an overview of MVI's history, mission, vision, and work.

Publication date: November 2012

Region: Global

This fact sheet provides an update on the activities of the PATH Rotavirus Vaccine Program, which aims to dramatically reduce the typical 10- to 15-year timeline between introduction of new vaccines in wealthy countries and their availability in the developing world. Activities include measuring disease burden, determining vaccine efficacy and safety in developing countries, communicating the value of rotavirus vaccines, and generating information on the health economics of rotavirus vaccination.

Author: Phillips D

Publication date: April 2007

Region: Global

This issue of PATH Today describes PATH's multipronged approach to eliminating malaria in Africa and the development of semisynthetic artemisinin, a key ingredient in malaria treatment. It includes updates on PATH's work to prevent diarrhea in Cambodia and to diagnose cervical cancer. It also contains a profile of Dean Allen, CEO of McKinstry and PATH's board treasurer.

Publication date: May 2013

Region: Global

Part of series: PATH Today

This set of fact sheets details technical activities of PATH's Japanese encephalitis project, with an aim to inform future efforts and programs. The fact sheets were developed as a supplement to PATH's Japanese Encephalitis Project: Collaboration and Commitment to Protect Asia's Children. Topics covered include surveillance of disease burden and disability, cost-effectiveness analysis, diagnostics, advocacy, vaccine development, and vaccine introduction.

Publication date: December 2009

Region: Global

This report summarizes the activities and achievements of PATH's Japanese encephalitis project (2003–2009), which aimed to accelerate availability of a safe and efficacious vaccine to vulnerable communities throughout Asia. Technical fact sheets bundled with the report provide guidance on disease surveillance, cost-effectiveness, advocacy, vaccine introduction, and more. The report is available as one large file or as four smaller files for easier downloading.

Publication date: October 2010

Region: Asia

This fact sheet highlights PATH's work to develop a vaccine against respiratory syncytial virus (RSV) with the potential to help control RSV in the developing world through prevention.

Publication date: September 2012

Region: Global

This fact sheet outlines the different approaches that project Optimize, a World Health Organization and PATH collaboration, is testing to demonstrate that a consumption‐based system that uses service-delivery-level data can have a beneficial impact on inventory management, stock levels, and vaccine wastage.

Publication date: July 2012

Region: Global

Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author: Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Publication date: June 2011

Region: Africa

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical cancer prevention and control on global health and development agendas.

Publication date: April 2011

Region: Global

This issue of Outlook provides an update on opportunities for preventing cervical cancer through vaccination and screening. It summarizes recent evidence on the safety and efficacy of human papillomavirus vaccines as well as successful approaches for screening and treatment in low-resource areas. Other topics include cost-effectiveness, communication and training, and implications for policy and programs.

Author: Murray M

Publication date: May 2010

Region: Global

Part of series: Outlook

This overview describes how PATH has developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global health contain an aluminum salt adjuvant or its equivalent (such as aluminum hydroxide, aluminum phosphate, or calcium phosphate) and would benefit from the technology.

Publication date: October 2012

Region: Global

Publication date: 2006

Region: Asia

This fact sheet provides an overview of PATH's work in protecting children from diarrheal disease.

Publication date: September 2012

Region: Global

Part of series: PATH's areas of focus fact sheets

This fact sheet provides information about the partnerships and commitments that helped the Government of India introduce a landmark strategy to vaccinate children at highest risk of Japanese encephalitis. Campaigns in 2006 reached more than 9 million children, and the target population in 2007 exceeds 23 million.

Author: Phillips D

Publication date: 2007

Region: Asia

This fact sheet describes PATH's activities to increase the coverage and timeliness of hepatitis B birth dose vaccination in Vietnam.

Publication date: July 2012

Region: Asia

The Optimize project, a collaboration between PATH and the World Health Organization, commissioned this white paper to examine the issues influencing vaccine producer willingness to advance, adopt, and commercialize value-added technologies for vaccines for low-income and lower-middle-income country markets.

Author: Gilchrist S

Publication date: November 2009

Region: Global

This eight-page paper on local advocacy was written for doctors, nurses, and health educators. It provides practical suggestions for grassroots initiatives supporting immunization and incorporates the insights of co-author Dr. Robert Aston, an immunization advocate from the U.K.

Author: Wittet S; Aston R

Publication date: 2000

Region: Global

Part of series: CVP Occasional Papers